Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 58,149 $ 4,001
Prepaid expenses 88,821 37,237
Total current assets 146,970 41,238
Property and equipment, net 126 882
Other assets:    
Patents, net 1,139,255 1,219,484
Goodwill 166,000 166,000
Deposits-other 3,575 2,315
Total other assets 1,308,830 1,387,799
Total Assets 1,455,926 1,429,919
Current liabilities:    
Notes payable - related party 1,702,300
Notes and debentures payable 39,138 94,764
Accounts payable and accrued expenses 615,815 597,843
Accrued interest payable - related party 468,260
Accrued interest payable 26,051
Total current liabilities 654,953 2,889,218
Long term debt:    
Notes payable - related party, net of discounts 120,508
Total Liabilities 775,461 2,889,218
Stockholders' equity (deficiency):    
Preferred stock, Series A convertible, $0.0002 par value, 500,000 shares authorized; 345,000 shares issued and outstanding at December 31, 2019 and 2018 69 69
Common stock $0.0002 par value, 1,500,000,000 shares authorized;193,521,506 and 68,474,520 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively 38,704 13,695
Additional paid-in capital 6,135,885 2,166,745
Accumulated deficit (5,494,193) (3,639,808)
Total Stockholders' Equity (Deficiency) 680,465 (1,459,299)
Total Liabilities and Stockholders' Equity (Deficiency) $ 1,455,926 $ 1,429,919